Evaluating gold standard corpora against gene/protein tagging solutions and lexical resources
© Rebholz-Schuhmann et al.; licensee BioMed Central Ltd. 2013
Received: 21 December 2012
Accepted: 11 September 2013
Published: 11 October 2013
The identification of protein and gene names (PGNs) from the scientific literature requires semantic resources: Terminological and lexical resources deliver the term candidates into PGN tagging solutions and the gold standard corpora (GSC) train them to identify term parameters and contextual features. Ideally all three resources, i.e. corpora, lexica and taggers, cover the same domain knowledge, and thus support identification of the same types of PGNs and cover all of them. Unfortunately, none of the three serves as a predominant standard and for this reason it is worth exploring, how these three resources comply with each other. We systematically compare different PGN taggers against publicly available corpora and analyze the impact of the included lexical resource in their performance. In particular, we determine the performance gains through false positive filtering, which contributes to the disambiguation of identified PGNs.
In general, machine learning approaches (ML-Tag) for PGN tagging show higher F1-measure performance against the BioCreative-II and Jnlpba GSCs (exact matching), whereas the lexicon based approaches (LexTag) in combination with disambiguation methods show better results on FsuPrge and PennBio. The ML-Tag solutions balance precision and recall, whereas the LexTag solutions have different precision and recall profiles at the same F1-measure across all corpora. Higher recall is achieved with larger lexical resources, which also introduce more noise (false positive results). The ML-Tag solutions certainly perform best, if the test corpus is from the same GSC as the training corpus. As expected, the false negative errors characterize the test corpora and – on the other hand – the profiles of the false positive mistakes characterize the tagging solutions. Lex-Tag solutions that are based on a large terminological resource in combination with false positive filtering produce better results, which, in addition, provide concept identifiers from a knowledge source in contrast to ML-Tag solutions.
The standard ML-Tag solutions achieve high performance, but not across all corpora, and thus should be trained using several different corpora to reduce possible biases. The LexTag solutions have different profiles for their precision and recall performance, but with similar F1-measure. This result is surprising and suggests that they cover a portion of the most common naming standards, but cope differently with the term variability across the corpora. The false positive filtering applied to LexTag solutions does improve the results by increasing their precision without compromising significantly their recall. The harmonisation of the annotation schemes in combination with standardized lexical resources in the tagging solutions will enable their comparability and will pave the way for a shared standard.
The integration of the biomedical literature into the infrastructure of other biomedical data resources requires the identification of entities and concepts, such as proteins and gene named entities [1, 2]. Furthermore, the entities have to be linked to specific database entries to achieve interoperability between all data resources (called “grounding” or “normalisation”) [3–5]. Once genes and other entities have been correctly identified, the different data resources and information types can be explored in concerto: Genes can be attributed with known facts such as associated diseases or novel drug candidates [6, 7].
“Which gene did you mean?”
Biologically, a gene is given by one or several genetic sequences that reside on one or several locations on the DNA (genetic loci). According to semantic formalisms a gene is a disposition which is described by the given genetic sequence. By contrast, a protein, a gene product, is a class of molecules with specific properties: composed of amino acids, having a structure and specific functions. A gene can be analysed by sequencing, but the observation of a protein and its functions requires more complex experimental setups. Eventually, observations about proteins (and genes) are kept in reference databases, like UniProt  for proteins or the NCBI Gene database  (formerly known as Entrez Gene), which also contribute with unique identifiers for grounding or normalisation .
Scientists frequently do not distinguish between the mention of a gene or a protein in their publications, since the gene is – in general – transcribed and translated into a protein anyways, i.e. the gene produces multiple instances of this particular protein type, which then exposes their function . In principle, we should have for every protein type a unique database entry which contains the reference information such as a unique identifier, the protein properties and also the names (“labels”) that would help to recognize the protein type in text, called protein and gene names (PGNs). Unfortunately, the existing resources are not quite as comprehensive yet.
More than 500,000 database entities are available that refer to protein types, which also contribute with several million names, synonyms, acronyms, hypernyms and morphological term variants . These names certainly comply with established nomenclature guidelines, but the reporting in the scientific literature is not similarly standardised and produces new term variants on a daily basis [13–15].
Standards for protein and gene names
There are several “standard” approaches to validate a PGN identified in text. A first approach is to consult the naming guidelines [16–18], to discover that the name (1) may represent a recognized macromolecule (e.g., “hemoglobulin”, “prolactin”), (2) may state the function of the gene or protein (e.g., “methyl-transferase”), (3) may state part of the structure of a protein (e.g., “Cytochrome c oxidase subunit 2”), (4) may indicate that the protein is part of a process (e.g., “Mitochondrial fission process protein 1”), (5) may indicate its action on a target (e.g., “DNA gyrase inhibitor”), (6) may induce a phenotype (e.g., “protein hunchback”), (7) may express chemical or physical properties (e.g., “37.8 kD protein”), or (8) may just be similar to another known protein or gene (e.g., “Myc homolog protein”).
A second and simpler approach, which is another standard, would be looking up the name in a reference database, where the PGN may be linked to a single entry (“unique name”), to several data entries (“polysemous term”), or to no entry at all (“unknown PGN”). A third approach would imply using a PGN tagger, e.g. “Banner”  a state of the art machine learning based tagger, and any finding of a PGN would be considered a true positive ignoring for the moment missed terms (false negatives, FN) and the wrongly identified terms (false positives, FP). Other tagging solutions have been suggested and tested as well, but may be used to a lesser degree . A preliminary comparison of ML-Tag solutions has already been performed , but was executed to judge methods for the identification of protein interactions from the scientific literature, and as a consequence did not cover the same scope as this analysis.
A number of gold standard corpora have been delivered to the public for the evaluation of PGN tagging solutions
Subset of Genia
Gene regulatory processes
Considering the different solutions to represent the same or similar standards, the question arises, how these different solutions relate to each other. Can we characterize, which portion of the semantics representation they share and where they differ? Although Banner is only one piece in the puzzle, it can be used as the starting point: first as a means to judge the compliance of the GSCs and second, as a means to compare against other PGN tagging solutions measured across all corpora.
The PGN tagging solutions are incorporate different components, i.e. lexical resources or trained machine-learning based entity recognizers
Is Banner the best tagging solution?
In the search of the best tagging solution, a number of hypotheses and test scenarios can be evaluated. State of the art PGN tagging solutions like Banner have not fully solved the PGN tagging task yet, the question remains whether it is possible to introduce a solution that performs better than Banner. It is easy to derive that Banner will certainly perform best on the BioCreative II corpus, which has been used to train the tagging solution, but how big is the performance loss, when we evaluate it on other GSCs?
It is also possible to evaluate PGN tagging solutions that have been trained on other GSC, e.g. Abner  (BioCreative-I) and Abner (Jnlpba), and compare them against Banner, leading to the obvious assumption that each solution may achieve better performance on the test corpus of the GSC they have been trained on. But which PGN tagger will perform best across all GSCs? The answer to this question requires that all PGN tagging solutions are tested against all GSCs.
It is also possible to explore PGN tagging solutions that have not been trained on any of the GSCs, e.g. dictionary lookup based solutions from the Whatizit  infrastructure. Several taggers are available that can be distinguished according to the lexical resources that have been incorporated into the annotation solution. Two questions arise: Which one performs best and on which GSC, and is it possible to correlate the tagging performance with the type of lexical resource that has been incorporated?
Another observation results from the previous considerations. If we test a selection of PGN tagging solutions across different GSCs, then we will find out that the taggers miss annotations (FNs) that are specific for one GSC in contrast to another, and that some tagging solutions are more alike in the production of unconfirmed annotations (FPs) than others. It becomes clear, that the PGN taggers may have similar FP profiles and a given GSC may induce similar FN profiles. Are these profiles giving us better insights, which setup for a PGN tagging solution is required to achieve the best performance on a given corpus or are selected corpora even more characteristic for a given set of PGNs after all? Even beyond this result, can we better analyse what distribution of PGN representations we would have to expect in the scientific literature in general?
It becomes clear that the comparison of as many PGN tagging solutions against as many GSCs as available leads to a matrix where each solution shows its best fit to a GSC and eventually, it becomes possible to reverse engineer which resources induce a PGN tagging solution that produces the best results against the given GSC.
How to evaluate a PGN mention?
A priori, it is only necessary to apply all PGN tagging solutions against all corpora, count the true positives, false positives and false negatives and finally calculate precision, recall and F1-measure. Any GSC – in its own rights – would claim this result as the only correct solution. Unfortunately, as it is often the case, a more complex solution is required to produce results that are independent from a single corpus.
Ideally, we would like to measure the correct assignment of an identifier to the PGN mention in the text, where the identifier points to an entry in the reference database . Since PGN mentions are often polysemous and have been reused in a number of database entries, it is impossible to derive automatically the identifier which should be the preferred choice for the author. A recent experiment has also shown that authors as well fail to use database entries – even when supported by experts for doing so – and rather prefer to use terminology only when specifying PGNs in theirs manuscripts [28–30]. It is in the same way impossible to make a clear distinction between gene mentions and protein mentions, and name ambiguities between genes and proteins, e.g. 'hypA’ versus 'HypA’, may result from the annotation guidelines .
The term boundaries are certainly crucial for the characterization of the term and its semantics. Again, it has been claimed that the difficulties in determining the correct term boundaries do result from the complexity of the naming guidelines, which – in this case – have been used for the production of a GSC . As an example, the organism names preceding a protein name may or may not be part of the protein name. The authors address the problems by defining the tagging of proteins as the prime target of the extraction task, and also distinguish the protein tags and the long-form tags as two annotation types, where the latter is formed by optionally extending the boundaries of the protein tag whenever the name boundaries are difficult to determine.
In essence, exact boundary matching gives clear evaluation guidelines, but will ignore term variability, i.e. ignores alternative annotations by a PGN tagging solution that does cope with term variability. When relaxing the boundary criteria, either by treating morphological term variability as a single entry (e.g. “HZF-7” vs. “HZF-7 protein”) or by the use of flexible matching  (e.g. cosine similarity, nestedness) or by allowing alternative term mentions (see BioCreative II, Alternative Gene List) the performance of the tagging solutions increases, but the precise interpretation of the results is reduced.
The following section gives an overview on different solutions for PGN tagging. In principle, a classifier can be trained on a GSC and then correctly identifies the PGN boundaries (“mention identification”), but would not attribute a database identifier to the PGN mention. The latter requires at least the use of one or more lexical resources.
PGN tagging solutions
Yamamoto distinguishes three different basic approaches for the identification of bio-entities: (a) exact and approximate string matching of entities [32, 33], (b) handcrafted rule-based approaches [34, 35], and (c) machine learning solutions [36, 37]. In addition, hybrid methods exist that integrate dictionaries with machine-learning approaches [38–40].
In principle all gene taggers fulfill a number of specific tasks. In the first place they identify a stretch of text that appears to represent a gene . This judgment requires that the morphological and syntactical structure of the gene is identified from text [42, 43]. The second step is the use of the contextual information to achieve term disambiguation or normalization of the named entity to a concept identifier [44, 45]. Both results can be achieved with a single processing step, for example in the use of dictionary based methods, but under-perform in terms of context-sensitive disambiguation of terms and entities in comparison to the ML approaches.
One solution for the gene identification is the use of a terminological resource that covers the full set of PGNs . Such resources have been generated from public scientific databases, e.g. from UniProtKb, or from a set of public resources in combination or can also be produced from the scientific literature [46–48]. The size of the terminological resources is crucial for the identification task, since only a comprehensive resource can ensure that all entities are identified . On the other hand, a larger terminological resource increases the noise ratio of the gene tagger, since less common and ambiguous gene names raise the false positive rate. Last but not least, the use of existing terminological resources leads to the advantage that the gene can be linked to their database resource [15, 44, 50, 51], which provides further relevant information about the gene.
As mentioned before, typical machine-learning solutions solve the mention identification task and have been trained and tested on a GSC [19, 52, 53]. Hybrid methods require the integration of a dictionary and a machine-learning approach [38–40].
Normalising gene entities
All available terminological resources have been compared against each other to identify the most comprehensive and the most universal ones
The dictionary-based tagging solutions make use of different terminological resources and the lexical resources have been compared as described here (Table 3). One lexical resource has been used as a component in a tagging solution (called “tagger” in the in Table 3) and has been applied to the lexical resource to annotate the content (called “corpus”). Two different methods for the matching have been applied: (1) exact matching (upper part of the table), and (2) matching with morphological variability (“alias” matching, lower part). The cross-tagging shows the intersections between the different resources and overall it becomes clear, which terminological resource comprises fully or partially one of the other resources.
The third type of normalisation, which is the most advanced one, would select the most appropriate reference to a database entry ("concept normalisation"), but would not allow mulitple references to database entries.
Different approaches have been proposed to normalize the entities, but no complete solution has been presented yet. Approaches that anticipate normalization are more restrictive in contrast to other PGN taggers, since they attempt to narrow the selection down to the most specific assignment amongst all candidates. Normalisation approaches include the following solutions: (1) delivery of all the entities that could be resolved to the PGN, (2) selection of a species that is automatically used for the normalization independently from the mention of any other species in the text, (3) selection of the species from the text that could indicate the right resolution, and (4) use of genomic information and database information for the gene normalization [44, 51, 54–57]. A toolkit for the normalisation is available from  and the evaluation has been addressed as part of the BioCreative III challenge .
Combining different identification approaches for genes leads to a modular setup that enables shaping the outcomes to the demands of the identification system. Both, high recall versus high precision can be achieved through different system setups . Ultimately, the tagging solutions have to comply with the lexical resources, with the coding standards and with the GSCs for benchmarking measurements to demonstrate the best performances.
In this study, we evaluate and compare the performance of several PGN tagging solutions against available PGN gold standard corpora. Then, we analyse which features of specific PGN taggers lead to a drop in their performance, and what characteristics of the GSCs influence their performances. Furthermore, we analyse the size of the lexical resources and the impact in their performance, and to which extend false positive filtering improves the results. Finally, we compare the different tagging solutions and perform error analysis. To do so, we generate false positive and false negative profiles for each tagging experiment and compare the profiles across tagging solutions and corpora to describe the error profile that is characteristic for each tagger-corpus pair.
Materials and methods
In this section, we present the GSCs and annotation solutions used in this work. The corpora and annotation solutions have been standardized to a common format (IeXML) , which allows an easier integration of the different components of the experiments. The evaluation tool used in this work has been developed and extensively tested as part of the CALBC projecta.
Gold standard corpora
Gold standard corpora have different profiles, e.g. size, topic, release date, and annotation guidelines that will impact the performance of the tagging solutions. Table 1 contains statistics of the different selected corpora.
The Jnlpba corpus is based on the Genia corpus , which contains annotation for different entity types linked to molecular biology such as PGN, cell type, and cell line, all being compliant with the Genia ontology.
The BioCreative-II corpus covers human genes and proteins and contains sentences instead of complete Medline® abstracts . It makes use of an alternative gene-list in addition to the regular list of genes for example, the GL (= GeneList) contains (1) P00027967A0207 | 11 31 | secretory HI antibodies, while the AGL (= Alt Gene List) also includes: (2) P00027967A0207 | 11 21 | secretory HI, (3) P00027967A0207 | 20 21 | HI, and (4) P00027967A0207 | 20 31 | HI antibodies for the same annotation example.
The Medline abstracts in PennBio have been developed with a focus on oncology . The FsuPrge corpus is the largest of all and has a focus on molecular mechanisms such as gene regulation.
We have tested several tagging solutions, with different underlying approaches. First, we have used state of the art ML-Tag approaches for gene mention identification. Second, we have used standard LexTag solutions where different terminological resources for PGNs have been integrated with and without disambiguation techniques. Last, we have combined the first and the second type to filter out false positives after dictionary lookup.
The ML-Tag approaches comprised Abner (BC1) trained on BioCreative-I, Abner (Jnlpba) trained on Jnlpba, and two taggers trained on BioCreative-II (Banner, “Chang2”) based on Conditional Random Fields (CRF) [20, 62]. The Banner tagger has been downloaded from the distribution siteb. The Chang2 tagger is a CRF model trained on BioCreative-II data with a set of features as given in : (1) all character n-grams of length 2 to 4, (2) inclusion of capitalization (token starts or ends with a Capital letter, or Capital letters only etc.), (3) length of the tokens (one character, two characters, between three and five), (4) inclusion of digits (1 digit, 2 digits, only digits), and (5) contained punctuation symbol or a Greek character. In addition a contextual window of plus or minus 2 tokens is employed (called “offset conjunctions”). The model is implemented as CRF (using mallet).
For the LexTag solutions, we tested publicly available Whatizit modules from UKPMC and other research (cf. Table 2) [27, 63]. In addition, we have compared the two latest versions of the Biothesaurus (version 6.0 and 7.0, GP6 and GP7, respectively) as part of the existing solutions to identify the importance of the lexical resource.
SwissProt (SP) is the Whatizit-SwissProt module integrated into different text mining solutions such as EBIMed  and PCorral . It uses terms retrieved from the SwissProt subset of UniProtKb obtained in 2007. SP(GP7) is the updated version, which comprises the full selection of SwissProt PGNs from Biothesaurus 7.0. The tagging of genes applies morphological variability to terms, i.e. accepting separators ([- /]), initial capitalization, and singular-plural variability (“alias matching”), since this morphological variability is very common in the use of gene names . This approach is similar to approximate string matching, e.g. Levenstein distance, but is more specific and thus better suitable for the comparison of PGN terms. Alternative methods include the automatic generation of a large dictionary resource containing all terms exposing the same term variability and then apply exact matching .
Finally, all tagged PGNs will be removed that are too unspecific, i.e. those terms that are part of the general English language and would be difficult to attribute to a specific gene or protein. This approach applies to all PGNs that appear in the British National Corpus (BNC)c with a frequency rate that is higher than the one of “insulin” (“basic disambiguation” or “BNC disambiguation”). It has been used in all LexTag solutions.
The GP7 solution makes use of the full content from Biothesaurus 7.0, applies morphological variability and basic BNC disambiguation only. Biolexicon integrates the full BioLexicon content into the same approach. The two solutions Wh-Ukpmc and Wh-Ukpmc (GP7) implement the same solution as before with Biothesaurus 6.0 and 7.0, respectively, and in addition we apply FP filtering with the Chang2 tagger after the basic BNC disambiguation to increase precision (“false positive filtering”).
The Table 3 gives an overview on the content used for building the dictionary-based solutions and demonstrates how the lexical resources differ in their size and content. The comparison makes use of exact and alias matching (see above) where a dictionary is incorporated into a lexical tagger (see above) for the matching of terms in the other lexical resource. According to our manual evaluation, GP7 in contrast to GP6 exposes reduced term variability across the resource to be more compliant with the naming standards in the biomedical research community.
Finally, the Gnat gene mention tagger and the gene normalization solution have been tested against the corpora . The Gnat gene normalisation mode has been used, since the gene mention mode of Gnat is based on Banner. The tagger has been applied in different modes using only the dictionary for human genes (GNAT/hum.) or for all species (GNAT/all).
In the latter case, the full set comprises 11 dictionaries for human and the most common model organisms (in total 80,000 entries).
For all tagging experiments against the corpora, we have calculated Precision, Recall and F-measure defined as: Precision , and Recall , where X I is all entities identified by the PGN taggers and X M is all entities which are (manually) annotated in the GSC. The F1-measure has been calculated as .
In addition, and in order to obtain a better understanding of the similarities and differences of the taggers, we have collected and counted the FP and FN results separately, sorted them according to their frequency and selected the most frequent errors for our analysis (N=100, (Additional file 1): Tables S10, S11, S12 and S13). The FP results from all experiments have been normalized to produce the representation of the FP profile, i.e. the FP results from each corpus formed a single entry in the normalized vector. The FP profiles were populated with the FP error frequency and have then been used to measure the correlation between the error profiles. The FN profiles were produced in the same way using the FP error frequencies. The same profiles were exploited for the similarity comparisons as well as clustering of the results (using R × 64 220.127.116.11), based on a hierarchical clustering where at each iteration step the distances between the clusters is determined by the Lance-Williams dissimilarity update formula and by the complete linkage method that supports identification of similar clustersd.
To calculate precision, recall and F1-measure, the evaluation of the annotated documents against the corpora has been performed with exact matching, but as well with a more relaxed matching approach named cos98 matching . For the cos98 matching, all the tokens in the text receive a weight according to their inverse document frequency across the Medline corpus. The similarity of two annotations is calculated as the cosine similarity between all tokens and their weights in the two annotated strings. A high cos98 (cosine similarity > 0.98) score is achieved if the two annotated strings differ only by terms with a low information content, such as “the” or “protein”. In the case of BioCreative-II, only the gene list has been considered during exact evaluation, and the whole gene list in combination with the alternative gene list has been used for the correlation in the cos98 matching evaluation. All results and descriptions of the used systems are also available through the CALBC League Table .
Since the lexical resources – in essence – have been derived from the biomedical reference databases, they are considered to represent the domain knowledge. If a LexTag solution produces a low FN error rate on a GSC then we call the tagger complete with regards to the corpus. If a LexTag solution produces a low FP error rate on a GSC then we call the corpus complete with regards to the tagger. If both conditions are true, then we call the tagger compliant with the corpus. We call two PGN tagging solutions compliant, if they are compliant against the same corpus. If they only have very similar FP and FN profiles against a corpus, we call them replaceable.
Categorisation of FP and FN results
For better assessment of the FP and FN results, a selection of the 15 most frequent FP and FN results, respectively, for all pairs composed of a corpus and a tagging solution has been made. This approach is suitable for the two following reasons. First, it allows comparing the corpora, although the corpora have different sizes and different annotation standards, and thus they produce different amounts of errors which limit their comparability if all FP and all FN results have been considered. And second, the removal of the most frequent mistakes is a common approach to improve the quality of a tagging solution against a corpus.
We can expect – from a theoretical point of view – that the tagging solutions will produce similar FP results across the different corpora under the assumption that the corpora have been extracted from the same collection of documents. In our case, all corpora stem from Medline abstracts, but the topic of each one of them may differ. On the other hand, we would expect very similar FN results only for any single corpus but not necessarily across all corpora, since the corpora do not exactly follow the same annotation standards.
This table gives a schema for categorizing terms into different types that help to sort and count the most frequent false positive and false negative results
T3, PU, LH
Confirmed by UniProtKb
Ras, c-fos, Wnt
a-PG with preserved semantics
Ras gene, p53 protein, Src family
a-PG with modified semantics
Confirmed by UniProtKb
E-cadherin, beta-catenin, glucocorticoid receptor
Specific to biomedical scientific text, excluding PGT
olymerase, prion, IgM
General English term
Occurring in non-scientific text
Plasma, renal, inhibitor, antibodies
In this manuscript, we present the results from a study comparing different PGN tagging solutions against all available GSCs and measuring performances. This research enables a better understanding, what contributions for the tagging performances can be expected from the components of a PGN tagging solution. Furthermore – by analysing the FP and FN errors – we explore the characteristics of the erroneous annotations by the different solutions.
Comparison of the lexical resources
The lexical resources differ in size and content, and also differ in the terminology that is shared between them when performing comparisons (cf. Table 3). The largest lexical resource, i.e. GP7, comprises 1,725,500 unique terms, whereas the smallest one, i.e. SwissProt, comprises only 228,893. Even the change from one version to the next, i.e. from GP6 to GP7, can lead to a strong increase of unique terms and term variants. Manual inspection has shown that GP7 incorporates a larger number of general English terms as term variants . The different lexical resources are homogeneous in the sense that they share significant portions of their content, and it can be expected that the larger resources improve the recall of LexTag solutions.
Evaluation of taggers across corpora: F1-measures
When using cos98 matching – in contrast to exact matching – the performance of the tagging solutions increases (5% to 10%, cf. Figure 4). As a result the performance differences between the individual PGN taggers measured against a single corpus become smaller for all corpora. More in detail, on FsuPrge and PennBio the differences are reduced to less than 10% (cos98 matching), except for the Gnat solutions and for Abner on PennBio.
When considering the alternative gene list, the performance of the tagging solutions increases similar to the cos98 evaluation on the other corpora. Selected data entries on the alternative gene list, which are marked as '**TP’ in the evaluation result, are only recognized by the ML-Tag solutions'and may have been added at a different time point than the other entries.
The performance of GNAT is lower than the one from the other solutions. This result is expected, since GNAT performs gene normalisation, i.e. it anticipates assigning a small selection of identifiers or a single identifier to the protein mention, which is a more complex task than gene mention annotation and automatically leads to reduction in recall.
Precision and recall evaluations
Comparing the PGN taggers across the different corpora leads to the conclusion that the performance on one corpus is predictive for the others (with a few exceptions), i.e. the order of corpora with regards to the performance is preserved across the different taggers, keeping in mind that the ML-Tag solutions perform best on the test corpora of the GSC used in their training. It is also remarkable that the recall performances of FsuPrge and PennBio are less than 5% apart across the different tagging solutions (apart from Abner (Jnlpba) and BioLexicon), indicating that PennBio and FsuPrge may comply better with the naming guidelines for gene entities.
Comparing FP and FN profiles between tagging solutions
FN results are indicative for the corpus
Since the FN results are defined by the corpus annotation standards, the taggers cluster together according to the corpus which they have been tested on, i.e. the tagging solutions produce similar FN results and can be called complete towards a given corpus if they produce a small number of FN results (see Materials and methods section). In addition, the FN results of the Chang2 tagger and Banner are very similar, since both have been trained on the same corpus, but the FN errors of SwissProt and Wh-Ukpmc(GP7) cluster as well together. Both have very similar precision and recall performances, and include similar lexical resources.
GenProt 7.0 (GP7) has the highest recall and thus the lowest number of FN errors due to its large terminological resource. Considering PennBio, the other three taggers miss mainly the acronym forms of the PGNs, which hints towards completeness of the corpus with standard acronyms. For other corpora, i.e. for FsuPrge and Jnlpba, the FN errors fall into the PGT category, which in general show high diversity.
Furthermore, the error profiles for FsuPrge across all tagging solutions show high similarity indicating that this corpus is complete in its annotation and thus robust against alternative tagging solutions. PGN tagging solutions have the lowest number of FN errors on the BioCreative-II corpus, indicating that this corpus is complete with regards to the tagging solutions. On the other hand, the SwissProt tagger generates across all corpora the same FN errors and is thus more consistent across all the corpora.
Overall, it can be concluded that BioCreative-II and FsuPrge are better compliant with the naming conventions in the biomedical domain than the other two corpora, i.e. induce FN errors due to GE and BMT terms at a lower rate. In particular FsuPrge generates comparable FN profiles across the different tagging solutions, indicating that less common PGT and a-PG terms are difficult to capture for all tagging solutions.
On the other side – as pointed out before – all corpora are predictive for the performance of the tagging solutions alike (see above).
FP results are indicative for the tagging solutions
FP errors represent those PGN mentions that have been identified by the tagging solution but do not match the annotations in the GSCs. Collecting and analyzing the set of false positives for each tagger and corpora pairs gives further insight for the types of errors produced by each tagger and for potential deficits in the annotation standards for the corpora. Clustering the FP profiles of the tagging solutions (cos98 matching, cf. Figure 7) reveals that – as expected – Chang2 and Banner produce similar FP results. Apart from this, Wh-Ukpmc(GP7) and SwissProt cluster together on the different corpora because they use similar terminological resources. GenProt 7.0 is clearly distinct from the other tagging solutions due to its high false positive rate.
The Pearson product-moment correlation coefficient has been determined for the different pairs, where each pair is composed of a PGN tagger and a corpus. The correlation calculations are based on the false positives results produced by the combination of a PGN tagger and a corpus (see Figure S9, in the Additional file 1). The correlation matrix shows the pair-wise similarity of the taggers across the different corpora with the strongest correlations given between Wh-Ukpmc(GP7) and SwissProt on PennBio, BioCreative-II and Jnlpba, and between Chang2 and Wh-Ukpmc(GP7) across the different corpora. This could be due to the use of the same FP filtering in both solutions. Again, GeneProt7.0 (GP7) is clearly distinct due to the lack of efficient FP filtering.
SwissProt and Wh-Ukpmc (GP7) show very similar results in FsuPrge and BioCreative-II again indicating that both corpora follow the same naming standards; and both show a slightly more complementary distribution of FP errors in Jnlpba and PennBio. This result shows that Wh7 produces a higher number of FP errors in the categories BMT and GE, which cannot be compensated through false positive filtering, since Chang2 is optimized for long-form and acronym PGNs in contrast to other biomedical terms.
From a methodological point of view, Wh-Ukpmc(GP7) has the advantage of a large lexical resource in combination with a precise ML-Tag solution for FP filtering, however, SP performs evenly well, although the terminological resource in SP has been kept to the standard of previous years. The best explanation is that the lexical resource of SwissProt incorporates the “conserved” part of the different terminological resources and generates only a small number of FP results.
FP and FN error distribution according to their relevance
The last analysis qualifies the FP and FN mistakes into categories, where each category is attributed a level of relevance for the PGN tagging task. The idea behind this approach is the observation that it is of higher importance to identify specific types of PGNs, e.g. the acronyms and the long-form mentions of PGNs (a-PG and PGT), in contrast to other mentions of PGNs, e.g. single character PGNs and terms representing general English concepts. In a more strict sense, if a corpus represents well the best conserved PGN terms and a tagging solution identifies them at a high performance measure, then this solution would fulfill the tagging task more reliably in comparison to either a corpus that has a higher variety of PGN annotations and misses out on well conserved PGN terms, or in comparison to a PGN tagging solution that rather identifies less specific terms (e.g., GE or BMT terms) or modifications of a-PG terms (e.g. ea-PG or xa-PG) in contrast to the most conserved PGN terms.
When analysing the annotations that are classified as “Core”, we discover that the biggest number of FN results occur in absolute and relative numbers on PennBio even for different tagging solutions, indicating that the annotations may not be conform with the standard biomedical data resources (non-compliant annotations). When considering Wh-Ukpmc (GP7) and SwissProt, a high portion of FP annotations belonging to the category “Core” can again be found for PennBio and Jnlpba, which indicates that not all PGN mentions have been annotated.
For the GP7 annotation solution we find that it over-generates annotations due to the lack of FP filtering for all corpora. On the other side, the BC2 corpus and FsuPrge do annotate the domain terminology well (inducing a small number of FN results), and also capture all PGN findings in the corpora, leaving little room for FP mistakes.
The presented analysis gives an overview on the different PGN tagging solutions against the GSCs. As expected, we can judge the tagging solutions against the GSCs, but – in principle – we can also judge the GSCs against the tagging solutions. For the former case, we learn that the annotations in the GSCs differ from each other leading to different FN profiles when measuring the performance of the taggers against the corpora. From the FP profiles, it is possible to derive that the corpora differ in their degree of completeness with regards to the tagging solutions.
Judging the tagging solutions
According to the FP rate of the taggers against the different GSCs allows for a better understanding of their working and propose approaches for their improvement. For example, the GP7 LexTag solution annotates a larger number of general English terms, e.g. “kinases”, which may or may not be relevant for the overall annotation of gene entities, but which in general is not included in the annotations of the different corpora (cf. Additional file 1: Tables S12 and S13).
As expected, the ML-Tag solutions perform better on the test set of the GSCs used for their training data, however they do show mediocre performance on the other corpora. In addition, the ML-Tag approaches do not deliver any clues for the normalization of the identified protein or gene entity. The biggest advantage of the ML-Tag approaches lies in the context-sensitive disambiguation of entities. This characteristic has been exploited in our experiments to improve the results of the LexTag solutions through FP filtering and showed the beneficial positive results. It became also clear that this FP filtering did not effectively work for general biomedical and general English terms, which were not recognized as FP annotations.
Applying FP filtering to the LexTag solutions increases precision and reduces recall as shown by our experiments, however it is not obvious what the best combination should be. More in detail, the different LexTag approaches produced very similar F1-measure performances, although they differ in their FP and FN profiles. A priori, it is an advantage to use a large lexical resource to increase the recall, but as can be seen from our results this approach largely reduces the precision. Fortunately, in the case of high recall and low precision, it is possible to apply FP filtering to the LexTag solution for lowering high recall, improving low precision and eventually the F1-measure performance after all.
The ML-Tag approaches reproduce the corpus annotations and have the following characteristics: (1) they can identify terms that might not be included in any lexical resource, (2) can cope with terminological variability, and (3) might still ignore a gene mention, if the context lacks to deliver the right clues. The combination of LexTag and ML-Tag solutions give the opportunity to combine efficient gene mention identification with gene normalization, and gene mention methods should perform better than gene normalization, since not all gene mentions are known to the lexical approach.
Judging the GSCs
The PennBio corpus and the FsuPrge corpus are the two corpora where the taggers tend to deliver their best performance. This could be explained by the fact that both corpora have been created more recently than the BioCreAtIve-II and the Jnlpba corpus and therefore they may better comply with naming conventions in the biological domain, i.e. comply better with latest annotation guidelines for genes and proteins.
The analysis of the FP and the FN errors has demonstrated that BioCreative-II and FsuPrge are more compliant with the terminological resources than the other two corpora are. It is surprising that the tagging solutions perform worse on the BioCreative-II corpus than on the FsuPrge corpus, but this can be explained by the fact that the single sentences in the BioCreative-II corpus have been selected in a way which is very specific to biomedical text mining, or – the other way around – the context in the FsuPrge full Medline abstracts contains a higher diversity of non-specific terms which reduces the performance of the tagging solutions.
When comparing the evaluation based on exact matching to the one from cos98 matching, the performance of all tagging solutions improves, but their relative performance against the different corpora stays the same, i.e. the order of the corpora measured by the performance against any given tagger is unchanged. In particular, the performance of the tagging solutions measured against Jnlpba and BioCreative-II improve when moving from exact to alias matching. This shows that these two corpora comprise more term variability in their annotations in comparison to the other two corpora, in particular since both corpora are smaller in their size.
The annotated corpora and the used terminological resources have been produced at different time intervals. As a result, a lexical resource from the past should be more compliant with a corpus that is outdated as well. This assumption could not be confirmed. It is rather the case that a larger lexical resource contains more spurious terms, generates more noise induced by the FP errors in the tagging results, and that other parameters are more relevant for the terminological variability in the corpora such as the annotation guidelines. Although the distinction between gene acronyms only and long-form PGNs on the one side, and between the genes in general and biomedical terms or general English terms can be difficult, we could identify that the identification of a-PG terms is best performed with a ML-Tag solution whereas the other forms are better identified with LexTag solutions including morphological or even syntactical variability.
The following findings can be drawn from our study. The ML-Tag approaches work best on the corpus where they have been trained on, which has been expected in the first place. Chang2 has been trained on BioCreative-II and performs best on BioCreative-II. Abner (BC1) used the BioCreative-I corpus and shows best performance on BioCreative-II. Abner (Jnlpba) has its best results on Jnlpba where it has been trained on. Unfortunately, their performances drop when moving to a different corpus. These results show that the tagger performances highly depend on the corpora that they have been trained on and thus they cannot generalize well from the learning corpora to the other corpora.
The LexTag solutions have different profiles for their precision and recall performances, but the F1-measure remains in a very similar range. This result is surprising and suggests that they all cover a portion of the best known naming standards, but cope differently with the term variability across the corpora.
The FP filtering does improve the results by increasing the precision of the LexTag solution without compromising the recall too extensively. This improvement is best if the LexTag solution delivers high recall already at the expense of low precision. Nonetheless, this approach still leads to lower performance in comparison to ML-Tag solutions only, which is again due to the fact that the ML-Tag solutions are performing better on the context-sensitive disambiguation and selection of annotation boundaries.
Finally, the topic and the structure of the corpus play an important role. BioCreative-II has a very narrow focus to specific biomedical sentences, which differs from the language in the other three corpora where contextual non-biomedical terms increase the FP error rate. This has to be considered when optimising tagging solutions against the given corpora.
As an overall conclusion, we suggest that the right selection of a LexTag solution can help to optimize the text mining output either for higher precision or for higher recall. If the best possible balanced F1-measure is required, then the ML-Tag solutions would be the best choice, but it would have to be trained on all available corpora . The combination of a LexTag solution and a ML-Tag solution for FP filtering is in addition a performing approach.
This work was funded by the EU Support Action grant 231727 (“CALBC”, http://www.calbc.eu) under the 7th EU Framework Programme within Theme “Intelligent Content and Semantics” (ICT 2007.4.2).
National ICT Australia (NICTA) is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program.
- Krauthammer M, Nenadic G: Term identification in the biomedical literature. J Biomed Inform. 2004, 37: 512-526.View ArticleGoogle Scholar
- Chun HW, Tsuruoka Y, Kim JD, Shiba R, Nagata N, Hishiki T, Tsujii J: Extraction of gene-disease relations from Medline using domain dictionaries and machine learning. Pac Symp Biocomput. 2006, 11: 4-15.Google Scholar
- Hirschman L, Burns GA, Krallinger M, Arighi C, Cohen KB, Valencia A, Wu CH, Chatr-Aryamontri A, Dowell KG, Huala E, Lourenco A, Nash R, Veuthey AL, Wiegers T, Winter AG: Text mining for the biocuration workflow. Database (Oxford). 2012, 2012: bas020.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Oellrich A, Hoehndorf R: Text-mining solutions for biomedical research: enabling integrative biology. Nat Rev Genet. 2012, 13 (12): 829-839.View ArticleGoogle Scholar
- Hahn U, Cohen KB, Garten Y, Shah NH: Mining the pharmacogenomics literature–a survey of the state of the art. Brief Bioinformatics. 2012, 13 (4): 460-494.View ArticleGoogle Scholar
- Baker NC, Hemminger BM: Mining connections between chemicals, proteins, and diseases extracted from Medline annotations. J Biomed Inform. 2010, 43 (4): 510-519.View ArticleGoogle Scholar
- Jimeno A, Jimenez-Ruiz E, Lee V, Gaudan S, Berlanga R, Rebholz-Schuhmann D: Assessment of disease named entity recognition on a corpus of annotated sentences. BMC Bioinformatics. 2008, 9 (Suppl 3): S3.View ArticleGoogle Scholar
- Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O’Donovan C, Redaschi N, Yeh LSL: UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004, 32 (suppl 1): D115-D119.View ArticleGoogle Scholar
- Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2011, 39 (suppl 1): D52-D57.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Kirsch H, Couto F: Facts from text–is text mining ready to deliver?. PLoS Biol. 2005, 3 (2): e65.View ArticleGoogle Scholar
- Mani I, Hu Z, Jang SB, Samuel K, Krause M, Phillips J, Wu CH: Protein name tagging guidelines: lessons learned. Comp Funct Genomics. 2005, 6: 72-76.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Kim JH, Yan Y, Dixit A, Friteyere C, Hoehndorf R, Backofen R, Lewin I: Evaluation and Cross-Comparison of Lexical Entities of Biological Interest (LexEBI). PLoS ONE. 2013, 8 (10): e75185.View ArticleGoogle Scholar
- Leitner F, Chatr-aryamontri A, Mardis SA, Ceol A, Krallinger M, Licata L, Hirschman L, Cesareni G, Valencia A: The FEBS, Letters/BioCreative II.5 experiment: making biological information accessible. Nat Biotechnol. 2010, 28 (9): 897-899.View ArticleGoogle Scholar
- Leser U, Hakenberg J: What makes a gene name? Named entity recognition in the biomedical literature. Brief Bioinformatics. 2005, 6 (4): 357-369.View ArticleGoogle Scholar
- Mons B: Which gene did you mean?. BMC Bioinformatics. 2005, 6: 142.View ArticleGoogle Scholar
- Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S, et al: Guidelines for human gene nomenclature. Genomics. 2002, 79 (4): 464-470.View ArticleGoogle Scholar
- Tamames J, Valencia A: The success (or not) of HUGO nomenclature. Genome Biol. 2006, 7 (5): 402.View ArticleGoogle Scholar
- Haeussler M, Gerner M, Bergman CM: Annotating genes and genomes with DNA sequences extracted from biomedical articles. Bioinformatics. 2011, 27 (7): 980-986.View ArticleGoogle Scholar
- Leaman R, Gonzalez G: BANNER: an executable survey of advances in biomedical named entity recognition. Pac Symp Biocomput. 2008, 13: 652-663.Google Scholar
- Settles B: ABNER: an open source tool for automatically tagging genes, proteins and other entity names in text. Bioinformatics. 2005, 21: 3191-3192.View ArticleGoogle Scholar
- Kabiljo R, Clegg AB, Shepherd AJ: A realistic assessment of methods for extracting gene/protein interactions from free text. BMC Bioinformatics. 2009, 10: 233.View ArticleGoogle Scholar
- Kim JD, Ohta T, Tateisi Y, Tsujii J: GENIA corpus–semantically annotated corpus for bio-textmining. Bioinformatics. 2003, 19 (Suppl 1): i180-i182.View ArticleGoogle Scholar
- Smith L, Tanabe L, Ando R, Kuo CJ, Chung IF, Hsu CN, Lin YS, Klinger R, Friedrich C, Ganchev K, Torii M, Liu H, Haddow B, Struble C, Povinelli R, Vlachos A, Baumgartner W, Hunter L, Carpenter B, Tsai R, Dai HJ, Liu F, Chen Y, Sun C, Katrenko S, Adriaans P, Blaschke C, Torres R, Neves M, Nakov P, et al: Overview of BioCreative II gene mention recognition. Genome Biol. 2008, 9 (Suppl 2): S2.View ArticleGoogle Scholar
- Kulick S, Bies A, Liberman M, Mandel M, McDonald R, Palmer M, Schein A, Ungar L: Integrated annotation for biomedical information extraction. HLT-NAACL 2004 Workshop: Biolink 2004, “Linking Biological Literature, Ontologies and Databases”. 2004, 61-68.Google Scholar
- Hahn U, Beisswanger E, Buyko E, Poprat M, Tomanek K, Wermter J: Semantic annotations for biology–a corpus development initiative at the Jena University Language & Information Engineering (JULIE) Lab. LREC 2008–Proceedings of the 6th International Conference on Language Resources and Evaluation. 2008, 28-30.Google Scholar
- Bada M, Eckert M, Evans D, Garcia K, Shipley K, Sitnikov D, Baumgartner WA, Cohen KB, Verspoor K, Blake JA, Hunter LE: Concept annotation in the CRAFT corpus. BMC Bioinformatics. 2012, 13: 161.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Arregui M, Gaudan S, Kirsch H, Jimeno A: Text processing through Web services: calling Whatizit. Bioinformatics (Oxford, England). 2008, 24 (2): 296-298.View ArticleGoogle Scholar
- Furlong LI, Dach H, Hofmann-Apitius M, Sanz F: OSIRISv1.2 a named entity recognition system for sequence variants of genes in biomedical literature. BMC Bioinformatics. 2008, 9: 84.View ArticleGoogle Scholar
- Krallinger M, Valencia A, Hirschman L: Linking genes to literaturetext mining, information extraction, and retrieval applications for biology. Genome Biol. 2008, 9 (Suppl 2): S8.View ArticleGoogle Scholar
- Lu Z: PubMed and beyond: a survey of web tools for searching biomedical literature. Database (Oxford). 2011, 2011: baq036.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Jimeno-Yepes A, Li C, Kafkas S, Lewin I, Kang N, Corbett P, Milward D, Buyko E, Beisswanger E, Hornbostel K, Kouznetsov A, Witte R, Laurila J, Baker C, Kuo CJ, Clematide S, Rinaldi F, Farkas R, Mira G, Hara K, Furlong L, Rautschka M, Lara Neves M, Pascual-Montano A, Wei Q, Collier N, Mahbub Chowdhury MF, Lavelli A, Berlanga R, et al: Assessment of NER solutions against the first and second CALBC Silver Standard Corpus. J Biomed Semantics. 2011, 2 (Suppl 5): S11.View ArticleGoogle Scholar
- Hanisch D, Fundel K, Mevissen HT, Zimmer R, Fluck J: ProMiner rule-based protein and gene entity recognition. BMC Bioinformatics. 2005, 6 (Suppl 1): S14.View ArticleGoogle Scholar
- Hanisch D, Fluck J, Mevissen HT, Zimmer R: Playing biology’s name game: identifying protein names in scientific text. Pac Symp Biocomput. 2003, 8: 403-414.Google Scholar
- Fukuda K, Tamura A, Tsunoda T, Takagi T: Toward information extraction: identifying protein names from biological papers. Pac Symp Biocomput. 1998, 707-718.Google Scholar
- Olsson F, Eriksson G, Franzén K, Asker L, Lidén P: Notions of correctness when evaluating protein name taggers. Proceedings of the 19th International Conference on Computational Linguistics - Volume 1, COLING ’02. Stroudsburg: Association for Computational Linguistics. 2002, 1-7.View ArticleGoogle Scholar
- Collier N, Nobata C, Tsujii Ji: Extracting the names of genes and gene products with a hidden Markov model. Proceedings of the 18th Conference on Computational Linguistics - Volume 1, COLING ’00. Stroudsburg: Association for Computational Linguistics. 2000, 201-207.View ArticleGoogle Scholar
- Kazama J, Makino T, Ohta Y, Tsujii J: Tuning support vector machines for biomedical named entity recognition. Proceedings of the ACL-02 Workshop on Natural Language Processing in the Biomedical Domain - Volume 3 BioMed ’02. Stroudsburg: Association for Computational Linguistics. 2002, 1-8.View ArticleGoogle Scholar
- Torii M, Hu Z, Wu CH, Liu H: BioTagger-GM: a gene/protein name recognition system. J Am Med Inform Assoc : JAMIA. 2009, 16 (2): 247-255.View ArticleGoogle Scholar
- Settles B: Biomedical named entity recognition using conditional random fields and rich feature sets. Proceedings of the International Joint Workshop on Natural Language Processing in Biomedicine and its Applications JNLPBA ’04. Stroudsburg: Association for Computational Linguistics. 2004, 104-107.View ArticleGoogle Scholar
- Roberts A, Gaizauskas R, Hepple M, Guo Y: Combining terminology resources and statistical methods for entity recognition: an evaluation. Proceedings of the Language Resources Evaluation Conference. 2008Google Scholar
- Hirschman L, Yeh A, Blaschke C, Valencia A: Overview of BioCreAtIvE: critical assessment of information extraction for biology. BMC Bioinformatics. 2005, 6 (Suppl 1): S1.View ArticleGoogle Scholar
- Hakenberg J, Plake C, Royer L, Strobelt H, Leser U, Schroeder M: Gene mention normalization and interaction extraction with context models and sentence motifs. Genome Biol. 2008, 9 (Suppl 2): S14.View ArticleGoogle Scholar
- Coden AR, Pakhomov SV, Ando RK, Duffy PH, Chute CG: Domain-specific language models and lexicons for tagging. J Biomed Inform. 2005, 38 (6): 422-430.View ArticleGoogle Scholar
- Hakenberg J, Plake C, Leaman R, Schroeder M, Gonzalez G: Inter-species normalization of gene mentions with GNAT. Bioinformatics (Oxford, England). 2008, 24 (16): i126-i132.View ArticleGoogle Scholar
- Tsuruoka Y, McNaught J, Ananiadou S: Normalizing biomedical terms by minimizing ambiguity and variability. BMC Bioinformatics. 2008, 9 (Suppl 3): S2.View ArticleGoogle Scholar
- Thompson P, McNaught J, Montemagni S, Calzolari N, del Gratta R, Lee V, Marchi S, Monachini M, Pezik P, Quochi V, Rupp C, Sasaki Y, Venturi G, Rebholz-Schuhmann D, Ananiadou S: The BioLexicon: a large-scale terminological resource for biomedical text mining. BMC Bioinformatics. 2011, 12: 397.View ArticleGoogle Scholar
- Liu H, Hu ZZ, Zhang J, Wu C: BioThesaurus: a web-based thesaurus of protein and gene names. Bioinformatics (Oxford, England). 2006, 22: 103-105.View ArticleGoogle Scholar
- Spasic I, Ananiadou S, McNaught J, Kumar A: Text mining and ontologies in biomedicine: making sense of raw text. Brief Bioinformatics. 2005, 6: 239-251.View ArticleGoogle Scholar
- Liu H, Hu ZZ, Torii M, Wu C, Friedman C: Quantitative assessment of dictionary-based protein named entity tagging. J Am Med Informa Assoc : JAMIA. 2006, 13 (5): 497-507.View ArticleGoogle Scholar
- Mitsumori T, Fation S, Murata M, Doi K, Doi H: Gene/protein name recognition based on support vector machine using dictionary as features. BMC Bioinformatics. 2005, 6 Suppl 1: S8.View ArticleGoogle Scholar
- Wermter J, Tomanek K, Hahn U: High-performance gene name normalization with GeNo. Bioinformatics. 2009, 25: 815-821.View ArticleGoogle Scholar
- Yamamoto K, Kudo T, Konagaya A, Matsumoto Y: Protein name tagging for biomedical annotation in text. Proceedings of the ACL 2003 Workshop on Natural Language Processing in Biomedicine - Volume 13, BioMed ’03, Stroudsburg, PA, USA: Association for Computational Linguistics. 2003, 65-72.View ArticleGoogle Scholar
- Papanikolaou N, Pafilis E, Nikolaou S, Ouzounis CA, Iliopoulos I, Promponas VJ: BioTextQuest: a web-based biomedical text mining suite for concept discovery. Bioinformatics. 2011, 27 (23): 3327-3328.View ArticleGoogle Scholar
- Morgan A, Lu Z, Wang X, Cohen A, Fluck J, Ruch P, Divoli A, Fundel K, Leaman R, Hakenberg J, Sun C, Liu Hh, Torres R, Krauthammer M, Lau W, Liu H, Hsu CN, Schuemie M, Cohen KB, Hirschman L: Overview of BioCreative II gene normalization. Genome Biol. 2008, 9 (Suppl 2): S3.View ArticleGoogle Scholar
- Chen L, Liu H, Friedman C: Gene name ambiguity of eukaryotic nomenclatures. Bioinformatics. 2005, 21 (2): 248-256.View ArticleGoogle Scholar
- Schijvenaars BJ, Mons B, Weeber M, Schuemie MJ, van Mulligen EM, Wain HM, Kors JA: Thesaurus-based disambiguation of gene symbols. BMC Bioinformatics. 2005, 6: 149.View ArticleGoogle Scholar
- Wang X, Tsujii J, Ananiadou S: Disambiguating the species of biomedical named entities using natural language parsers. Bioinformatics. 2010, 26: 661-667.View ArticleGoogle Scholar
- Huang M, Liu J, Zhu X: GeneTUKit: a software for document-level gene normalization. Bioinformatics. 2011, 27 (7): 1032-1033.View ArticleGoogle Scholar
- Lu Z, Kao HY, Wei CH, Huang M, Liu J, Kuo CJ, Hsu CN, Tsai RT, Dai HJ, Okazaki N, Cho HC, Gerner M, Solt I, Agarwal S, Liu F, Vishnyakova D, Ruch P, Romacker M, Rinaldi F, Bhattacharya S, Srinivasan P, Liu H, Torii M, Matos S, Campos D, Verspoor K, Livingston KM, Wilbur WJ: The gene normalization task in BioCreative III. BMC Bioinformatics. 2011, 12 (Suppl 8): S2.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Kirsch H, Nenadic G: IeXML: towards a framework for interoperability of text processing modules to improve annotation of semantic types in biomedical text. Proc. of BioLINK, ISMB 2006. 2006, Fortaleza BrazilGoogle Scholar
- Tanabe L, Xie N, Thom LH, Matten W, Wilbur WJ: GENETAG a tagged corpus for gene/protein named entity recognition. BMC Bioinformatics. 2005, 6 (Suppl 1): S3.View ArticleGoogle Scholar
- Chang YM, Kuo CJ, Huang HS, Lin YS, Hsu CN: Analysis and enhancement of conditional random fields gene mention taggers in BioCreative II challenge evaluation. LBM (Short Papers)’07. 2007, 1-1.http://ceur-ws.org/Vol-319/Paper4.pdf,Google Scholar
- McEntyre JR, Ananiadou S, Andrews S, Black WJ, Boulderstone R, Buttery P, Chaplin D, Chevuru S, Cobley N, Coleman LA, Davey P, Gupta B, Haji-Gholam L, Hawkins C, Horne A, Hubbard SJ, Kim JH, Lewin I, Lyte V, MacIntyre R, Mansoor S, Mason L, McNaught J, Newbold E, Nobata C, Ong E, Pillai S, Rebholz-Schuhmann D, Rosie H, Rowbotham R, et al: UKPMC: a full text article resource for the life sciences. Nucleic Acids Res. 2011, 39 (Database issue): D58-D65.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Kirsch H, Arregui M, Gaudan S, Riethoven M, Stoehr P: EBIMed–text crunching to gather facts for proteins from Medline. Bioinformatics. 2007, 23: e237-244.View ArticleGoogle Scholar
- Li C, Jimeno-Yepes A, Arregui M, Kirsch H, Rebholz-Schuhmann D: PCorral–interactive mining of protein interactions from MEDLINE. Database (Oxford). 2013, 2013: bat030.Google Scholar
- Kirsch H, Gaudan S, Rebholz-Schuhmann D: Distributed modules for text annotation and IE applied to the biomedical domain. Int J Med Inform. 2006, 75 (6): 496-500.View ArticleGoogle Scholar
- Rebholz-Schuhmann D, Kafkas S, Kim JH, Jimeno Yepes A, Lewin I: Monitoring named entity recognition: the League Table. J Biomed Semantics. 2013, 4 (1): 19.View ArticleGoogle Scholar
- Campos D, Matos S, Lewin I, Oliveira JL, Rebholz-Schuhmann D: Harmonization of gene/protein annotations: towards a gold standard MEDLINE. Bioinformatics. 2012, 28 (9): 1253-1261.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.